Pract Lab Med. 2021 Apr 14;25:e00220. doi: 10.1016/j.plabm.2021.e00220. eCollection 2021 May.
Evaluation of a new automated immunoassay for the quantification of anti-Müllerian hormone.
Practical laboratory medicine
Manuela Lotierzo, Victor Urbain, Anne-Marie Dupuy, Jean-Paul Cristol
Affiliations
Affiliations
- Département de Biochimie et Hormonologie, Centre de Ressources Biologiques, CHU de Montpellier, Montpellier, France.
- PhyMedExp, Université de Montpellier, INSERM, CNRS, Département de Biochimie et Hormonologie, Centre de Ressources Biologiques, CHU de Montpellier, Montpellier, France.
PMID: 34095410
PMCID: PMC8145750 DOI: 10.1016/j.plabm.2021.e00220
Abstract
OBJECTIVES: A newly developed fully automated Lumipulse G AMH method (Fujirebio Diagnostics) was recently introduced in clinical laboratories for quantitative determination of anti-Müllerian hormone (AMH) level in human serum or plasma. AMH has emerged as value-added biomarker in the assessment of ovarian reserve, in diagnosis of granulosa cells cancer and in the investigation of gonadal disorders. We compared Lumipulse G AMH assay performances with other methods largely applied for AMH measurements.
DESIGN AND METHODS: The Lumipulse G AMH method based on two-step sandwich chemiluminescence enzyme immunoassay was assessed on Lumipulse G600II analyzer. The evaluation study included imprecisions, sensitivity and linearity whereas a comparison study was performed on a heterogeneous population of 114 patients by using the Elecsys AMH Plus assay on COBAS 8000 e602 module (Roche Diagnostics).
RESULTS: Lumipulse G AMH system showed good repeatability (within-run imprecision) with CV values below 1% (0.5% and 0.9% for high and low serum pools). Similarly within-laboratory imprecision was assessed with CV values of 2.5% and 1.6% for high and low level controls respectively. A linearity regression formula of 1.0119x-0.067 with a coefficient of determination (r
CONCLUSIONS: The performance of Lumipulse G AMH system was highly comparable with that of Roche Elecsys AMH Plus assay although approximately 10% higher values of AMH levels were observed for Lumipulse AMH system at all range of concentrations. Nevertheless the Lumipulse G system seems to be largely suitable for quantitative determination of AMH level in small-scale laboratory because of the reduced size and the use of single cartridge per test assuring flexibility and easy handling.
© 2021 The Authors.
Keywords: Anti-Müllerian hormone; Assessment of ovarian reserve; Automated immunoassay; Emerging biomarker; Method comparison
Conflict of interest statement
None.
References
- J Endocrinol Invest. 2016 Nov;39(11):1259-1265 - PubMed
- Reprod Biomed Online. 2011 Oct;23(4):411-20 - PubMed
- Hum Reprod Update. 2014 May-Jun;20(3):370-85 - PubMed
- Mol Cell Endocrinol. 2003 Dec 15;211(1-2):85-90 - PubMed
- Trends Endocrinol Metab. 2003 Mar;14(2):91-7 - PubMed
- Clin Chem Lab Med. 2014 Aug;52(8):1143-52 - PubMed
- Hum Reprod. 2006 Dec;21(12):3103-7 - PubMed
- Reproduction. 2002 Nov;124(5):601-9 - PubMed
- Hum Reprod. 2002 Dec;17(12):3065-71 - PubMed
- Fertil Steril. 2013 Mar 15;99(4):963-9 - PubMed
- Rev Mal Respir. 2004 Feb;21(1):127-30 - PubMed
- Clin Biochem. 2016 Feb;49(3):260-7 - PubMed
- Int J Endocrinol. 2013;2013:674105 - PubMed
- J Clin Chem Clin Biochem. 1983 Nov;21(11):709-20 - PubMed
- Climacteric. 2015;18(6):777-89 - PubMed
- Stat Methods Med Res. 1999 Jun;8(2):135-60 - PubMed
Publication Types